Better survival seen in NSCLC patients who take beta blockers

01/15/2013 | News-Medical.Net

A new study has found beta blocker treatment was associated with better survival without distant metastases, improved disease-free survival and better overall survival among patients with non-small-cell lung cancer being treated with definitive radiotherapy compared with those who did not take beta blockers. The research appears in the Annals of Oncology.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN